licensed in the UK as a treatment for "idiopathic menorrhagia"
"may be particularly useful in women with idiopathic menorrhagia requiring (reversible) contraception" (1)
there is evidence that the Mirena system may result in smaller mean reduction in menstrual blood loss than endometrial destruction but women seem equally satisfied with the two treatments (2)
the Mirena system seems to lead to an improvement in quality of life similar to those after hysterectomy (2)
a Drugs and Therapeutics Bulletin review concluded that the "levonorgestrel intra-uterine system is a reasonable option for the treatment of menorrhagia in women who wish to avoid surgery and seems particularly suitable for women who also need contraception" (2)
Reference:
(1) Mirena. Summary of product characteristics, UK. Scheing Health Care Ltd, February 2001.
(2) Drugs and Therapeutics Bulletin (2001), 39 (11), 85-7.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.